Experiment summary for ENCSR550JJT

doi:10.17989/ENCSR550JJT

Summary

Status
released
Assay
ChIA-PET
Target
CTCF
Biosample summary
Homo sapiens activated naive CD4-positive, alpha-beta T cell male adult (43 years) treated with 10 ng/mL Interleukin-2 for 5 days, anti-CD3 and anti-CD28 coated beads for 7 days
Biosample Type
primary cell
Replication type
isogenic
Description
CTCF ChIA-PET in Naive_CD4_Activated_Day7
Treatments
10 ng/mL Interleukin-2 (UniProtKB:P60568) for 5 days, anti-CD3 and anti-CD28 coated beads for 7 days
Nucleic acid type
DNA
Size range
350-600
Lysis method
SDS
Fragmentation methods
sonication (Branson Sonifier 250)
Size selection method
BluePippin

Attribution

ENCODE4 project
Lab
Yijun Ruan, JAX
Award
UM1HG009409 (Yijun Ruan, JAX)
Project
ENCODE
External resources
Aliases
yijun-ruan:Naive_CD4_Activated_Day7_CTCF
Date submitted
August 3, 2020
Date released
July 21, 2021

Isogenic replicates

Isogenic replicate
Technical replicate
Summary
Biosample
Antibody
Library
21Homo sapiens male adult (43 years) activated naive CD4-positive, alpha-beta T primary cell treated with 10 ng/mL Interleukin-2 for 5 days, anti-CD3 and anti-CD28 coated beads for 7 daysENCBS338LVOENCAB635SXPENCLB282YTU
11Homo sapiens male adult (43 years) activated naive CD4-positive, alpha-beta T primary cell treated with 10 ng/mL Interleukin-2 for 5 days, anti-CD3 and anti-CD28 coated beads for 7 daysENCBS716JOOENCAB635SXPENCLB825EVF